242 related articles for article (PubMed ID: 28496328)
1. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients.
Chen HH; Chen DY; Lin CC; Chen YM; Lai KL; Lin CH
Ther Clin Risk Manag; 2017; 13():583-592. PubMed ID: 28496328
[TBL] [Abstract][Full Text] [Related]
2. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
3. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
4. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
[TBL] [Abstract][Full Text] [Related]
5. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
6. Risk of New-Onset Diabetes Mellitus Associated with Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study.
Nam SH; Kim M; Kim YJ; Ahn SM; Hong S; Lee CK; Yoo B; Oh JS; Kim YG
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456202
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
Salvarani C; Cantini F; Olivieri I
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
[TBL] [Abstract][Full Text] [Related]
8. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
9. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.
Grijalva CG; Chen L; Delzell E; Baddley JW; Beukelman T; Winthrop KL; Griffin MR; Herrinton LJ; Liu L; Ouellet-Hellstrom R; Patkar NM; Solomon DH; Lewis JD; Xie F; Saag KG; Curtis JR
JAMA; 2011 Dec; 306(21):2331-9. PubMed ID: 22056398
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
11. Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections.
Chiu YM; Lai MS; Chan KA
PLoS One; 2018; 13(4):e0196210. PubMed ID: 29694398
[TBL] [Abstract][Full Text] [Related]
12. [THE EFFECT OF BIOLOGIC THERAPY ON THE LIPID PROFILE OF RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) AND ANKYLOSING SPONDYLITIS (AS) PATIENTS].
Hassan S; Feld J; Cohen S; Zisman D
Harefuah; 2017 Jul; 156(7):446-450. PubMed ID: 28786273
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
15. Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study.
Machado MA; Bernatsky S; Bessette L; Nedjar H; Rahme E
BMC Musculoskelet Disord; 2016 Jul; 17():298. PubMed ID: 27431503
[TBL] [Abstract][Full Text] [Related]
16. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
[TBL] [Abstract][Full Text] [Related]
17. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
18. Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.
Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
Korean J Intern Med; 2022 May; 37(3):673-680. PubMed ID: 33706472
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.
Fantò M; Peragallo MS; Pietrosanti M; Di Rosa R; Picchianti Diamanti A; Salemi S; D'Amelio R
Intern Emerg Med; 2016 Feb; 11(1):31-40. PubMed ID: 26099279
[TBL] [Abstract][Full Text] [Related]
20. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.
Kawai VK; Grijalva CG; Arbogast PG; Curtis JR; Solomon DH; Delzell E; Chen L; Ouellet-Hellstrom R; Herrinton L; Liu L; Mitchell EF; Stein CM; Griffin MR
Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1085-94. PubMed ID: 23281339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
